The Patent Finder

Gador S.A.

Also on record
Records under this name other than the patents Gador S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Gador S.A.

PatentTitleStatus Expires Confidence
US 7,560,490Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
Term ended
Term ended Dec 20, 2022 · From the USPTO record
Term endedTerm ended Dec 20, 2022From the USPTO record
US 8,853,187Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
Term ended
Term ended Jun 12, 2022 · From the USPTO record
Term endedTerm ended Jun 12, 2022From the USPTO record
US 6,605,603Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
Term ended
Term ended Jul 27, 2021 · From the USPTO record
Term endedTerm ended Jul 27, 2021From the USPTO record
US 7,846,474Use of bisphosphonates for the treatment of osteogenesis imperfecta
Lapsed on the fee record
Ended Dec 7, 2018 · From the USPTO record
Lapsed on the fee recordEnded Dec 7, 2018From the USPTO record
US 6,864,228Use of bisphosphonates for the treatment of osteogenesis imperfecta
Lapsed on the fee record
Ended Mar 8, 2017 · From the USPTO record
Lapsed on the fee recordEnded Mar 8, 2017From the USPTO record
US 8,153,648Solid and crystalline dutasteride and processes for preparation thereof
Lapsed on the fee record
Ended Apr 10, 2016 · From the USPTO record
Lapsed on the fee recordEnded Apr 10, 2016From the USPTO record
US 7,345,183Process for obtaining norelgestromin in different relations of isomers E and Z
Lapsed on the fee record
Ended Mar 18, 2012 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2012From the USPTO record
US 6,476,223Method for obtaining N-[3(3-cyano-pyrazole[1,5-a]pyrimidine-7-yl)phenyl]-N-ethyl-acetamide
Lapsed on the fee record
Ended Nov 5, 2010 · From the USPTO record
Lapsed on the fee recordEnded Nov 5, 2010From the USPTO record
US 6,416,737Increasing bone strength with selected bisphosphonates
Lapsed on the fee record
Ended Jul 9, 2010 · From the USPTO record
Lapsed on the fee recordEnded Jul 9, 2010From the USPTO record
US 5,885,973Bone mass anabolic composition comprising olpadronate
Formerly held
Term ended
Term ended no later than Mar 23, 2019 · Low confidence
Term endedTerm ended no later than Mar 23, 2019Low confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited